Found: 25
Select item for more details and to access through your institution.
Are Providers and Patients Following Hormonal Therapy Guidelines for Patients Over the Age of 70? The Influence of CALGB 9343.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 121, doi. 10.1007/s10549-021-06358-6
- By:
- Publication type:
- Article
Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center.
- Published in:
- Cancer Reports, 2020, v. 3, n. 6, p. 1, doi. 10.1002/cnr2.1287
- By:
- Publication type:
- Article
ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7659, doi. 10.1245/s10434-022-12069-z
- By:
- Publication type:
- Article
Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7652, doi. 10.1245/s10434-022-12001-5
- By:
- Publication type:
- Article
Cardiovascular disease in cancer survivors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
HER2-Directed Treatment of Metastatic Breast Cancer: Unanswered Questions.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 176
- By:
- Publication type:
- Article
Adjuvant Endocrine Therapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 6, p. 541
- By:
- Publication type:
- Article
A community effort to reduce the black/white breast cancer mortality disparity in Chicago.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.
- Published in:
- 2013
- By:
- Publication type:
- Report
Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 24, p. 4954, doi. 10.1002/cam4.4843
- By:
- Publication type:
- Article
Patients With Positive Axillary Lymph Nodes: How to Use Genomic Assays.
- Published in:
- Current Treatment Options in Oncology, 2012, v. 13, n. 2, p. 240, doi. 10.1007/s11864-012-0187-3
- By:
- Publication type:
- Article
Treating Positive Axillary Disease in Elderly Breast Cancer Patients: The Impact of Age on Radiation Therapy.
- Published in:
- Breast Care, 2021, v. 16, n. 3, p. 276, doi. 10.1159/000508243
- By:
- Publication type:
- Article
Assessing the Quality of Race/Ethnicity, Tumor, and Breast Cancer Treatment Information in a Non-SEER State Registry.
- Published in:
- Journal of Registry Management, 2014, v. 41, n. 1, p. 24
- By:
- Publication type:
- Article
A Case of Hepatopulmonary Syndrome as a Complication of Metastatic Breast Cancer to the Liver.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2007, v. 46, n. 4, p. 397, doi. 10.1002/gcc.20419
- By:
- Publication type:
- Article
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00613-x
- By:
- Publication type:
- Article
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
- Published in:
- Medical Oncology, 2011, v. 28, p. 39, doi. 10.1007/s12032-010-9682-1
- By:
- Publication type:
- Article